全球疫苗市场综述

Overview on the glabal vaccine markets

目前世界上已有可预防26种传染病的疫苗产品,市场规模在300亿美元左右,到2020年全球疫苗市场将以7%的速度增长。以金砖国家为代表的新兴国家疫苗生产商则满足了超过50%的全球疫苗需求量,其中印度疫苗生产商国际化程度最高。截至2014年年底,7家印度疫苗企业的20余个疫苗通过了WHO预认证。巴西目前在免疫保护方面位居拉美国家首位,其国家免疫计划包含了26种疫苗。中国、巴西等新兴市场疫苗公司在研究新型HPV疫苗方面已经取得进展,HPV疫苗是目前世界上唯一一种可以预防宫颈癌的疫苗,2014年,全球HPV疫苗市场规模超过20亿美元。

Currently,there are 26 kinds of infectious diseases preventable vaccine products in the glabal market,with the market size of around$30billion,and the global vaccine industry will grow by 7% by 2020.In the BRIC countries as a representative of emerging countries vaccine manufacturers can meet over 50% of the global vaccine demand,India＇s highest degree of internationalization of vaccine manufacturers.By the end of 2014,more than 20 vaccines in seven Indian vaccine companies prequalified by the WHO.Brazil is currently ranked first in the immune protection in Latin America,its national immunization program contains 26 kinds of vaccines.In the China,Brazil and other emerging markets,the company has made progress in vaccine research of new HPV vaccines,HPV vaccine is currently the world＇s only a vaccine that can prevent cervical cancer.In 2014,the global market size of HPV vaccine was more than two billion US dollars.